Table 2.
Change in Primary Outcomes for Each 10-Minute Increase in Frequency of Yoga Practice, Adjusting for Baseline Outcome Levels, Age, and SAD
| Outcome | No. of Patients | Estimate | SE | 95% CI | P |
|---|---|---|---|---|---|
| MFSI-SF fatigue | 186 | ||||
| Immediately post treatment | −1.7 | 0.70 | −3.1 to −0.28 | .019 | |
| 3 months post treatment | −2.8 | 0.71 | −4.2 to −1.4 | < .001 | |
| SF-36 vitality | 186 | ||||
| Immediately post treatment | 2.1 | 0.85 | 0.40 to 3.75 | .016 | |
| 3 months post treatment | 2.5 | 0.85 | 0.77 to 4.14 | .0045 | |
| CES-D | 186 | ||||
| Immediately post treatment | −0.66 | 0.34 | −1.3 to 0.0039 | .051 | |
| 3 months post treatment | −0.56 | 0.34 | −1.2 to 0.10 | .098 | |
| Stimulated TNF-α* | 176 | ||||
| Immediately post treatment | −0.021 | 0.020 | −0.060 to 0.018 | .28 | |
| 3 months post treatment | −0.038 | 0.020 | −0.079 to 0.0021 | .063 | |
| Stimulated IL-6* | 176 | ||||
| Immediately post treatment | −0.022 | 0.021 | −0.063 to 0.019 | .30 | |
| 3 months post treatment | −0.056 | 0.022 | −0.098 to −0.013 | .01 | |
| Stimulated IL-1β* | 176 | ||||
| Immediately post treatment | −0.034 | 0.035 | −0.10 to 0.035 | .33 | |
| 3 months post treatment | −0.078 | 0.036 | −0.15 to −0.0074 | .030 |
NOTE. Models used frequency of continuous yoga practice in place of group assignment to predict primary outcomes.
Abbreviations: CES-D, Center for Epidemiological Studies–Depression; IL-1β, interleukin-1 beta; IL-6, interleukin-6; MFSI-SF, Multidimensional Fatigue Symptom Inventory–Short Form; SAD, sagittal abdominal diameter; SF-36, Short Form-36; TNF-α, tumor necrosis factor alpha.
*
Stimulated cytokines are natural log transformed.